JPMorgan lowered the firm’s price target on Walgreens Boots Alliance to $20 from $30 and keeps an Overweight rating on the shares. The firm is adjusting estimates following last week’s earnings to reflect “the persistent headwinds identified by management” continuing into FY25, the analyst tells investors. While the near-term results have been challenging, the firm continues to view the new management team as “credible and executing the necessary steps to manage through industry-level headwinds,” leading to an Overweight rating, the analyst added.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on WBA:
- Walgreens Boots Alliance Stock (NASDAQ:WBA): Here’s Why TD Cowen Slashed its Price Target
- Boots chief quitting as Walgreens’ sale plan stalls, Reuters reports
- Walgreens Boots Alliance price target lowered to $13 from $20 at Truist
- Walgreens Boots Alliance price target lowered to $10 from $17 at Evercore ISI
- Walgreens Boots Alliance price target lowered to $11 from $22 at BofA
